Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,728,835 papers from all fields of science
Search
Sign In
Create Free Account
Tumor Progression
Known as:
cancer progression
, neoplasm progression
, neoplastic progression
A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
22 relations
BCL7A gene
BCL7A wt Allele
Cancer Cell Growth
Cancer Progression
Expand
Narrower (1)
Neoplastic Cell Transformation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
A. Mamoune
,
J. Kassis
,
+4 authors
A. Wells
Experimental Cell Research
2004
Corpus ID: 22480937
Highly Cited
2000
Highly Cited
2000
Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines.
M. Larramendy
,
M. Larramendy
,
+6 authors
Sakari Knuutila
Cancer Genetics and Cytogenetics
2000
Corpus ID: 24003191
Review
1999
Review
1999
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
M. Prados
,
C. Scott
,
+9 authors
W. Curran
International Journal of Radiation Oncology…
1999
Corpus ID: 34163814
Highly Cited
1997
Highly Cited
1997
Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon.
B. Shpitz
,
Y. Bomstein
,
+4 authors
Joelle Bernheim
American Journal of Surgery
1997
Corpus ID: 21371060
Review
1995
Review
1995
Is episialin/MUC1 involved in breast cancer progression?
J. Hilkens
,
H. Vos
,
+5 authors
C. Patriarca
Cancer Letters
1995
Corpus ID: 25755128
Highly Cited
1993
Highly Cited
1993
Integrin expression in cutaneous malignant melanoma: Association of the α3/β1 heterodimer with tumor progression
P. Natali
,
A. Bartolazzi
,
R. Cavaliere
,
A. Bigotti
,
M. Nicotra
1993
Corpus ID: 86390588
The cell‐surface heterodimers of the integrin family of molecules, which mediate cell‐cell and cell‐substratum interactions, are…
Expand
Highly Cited
1987
Highly Cited
1987
Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma.
N. Dracopoli
,
B. Alhadeff
,
A. Houghton
,
L. Old
Cancer Research
1987
Corpus ID: 24071505
Restriction fragment length polymorphisms at 61 autosomal and 7 X-linked loci were screened for heterozygosity in cell lines…
Expand
Highly Cited
1986
Highly Cited
1986
Cytogenetic heterogeneity: its role in tumor evolution.
S. Wolman
Cancer Genetics and Cytogenetics
1986
Corpus ID: 25723689
Highly Cited
1985
Highly Cited
1985
Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras plus v-myc oncogenes
M. Oshimura
,
Gilmer Tm
,
Barrett Jc
Nature
1985
Corpus ID: 4313774
Nonrandom chromosome rearrangements, observed in a variety of human and animal tumours1,2, are associated in some cases with…
Expand
Highly Cited
1977
Highly Cited
1977
Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression.
Mitsuo Takasugi
,
Annie Ramseyer
,
J. Takasugi
Cancer Research
1977
Corpus ID: 29617218
Lymphocytes isolated from the blood of patients and healthy donors include a population of cells that destroy target cells in the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE